跳至主要内容
临床试验/NCT06936397
NCT06936397招募中不适用

A Randomized Controlled EEG-GSR Study on the Effects of Cognitive Remediation Therapy on Neurophysiological and Emotional Regulation Markers in Schizophrenia

Beykoz University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月15日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
2
主要终点
Change from Baseline in P300 Amplitude Measured via EEG at 12 Weeks

研究概览

简要总结

This study aims to determine whether Cognitive Remediation Therapy (CRT) can improve attention, memory, and emotional regulation in people with schizophrenia. CRT is a structured program that includes exercises to strengthen cognitive skills such as problem-solving, working memory, and emotion regulation.

The study will recruit 60 participants: 30 individuals with schizophrenia and 30 healthy individuals of similar age and gender. Those with schizophrenia will be randomly assigned to either receive CRT or be placed on a waitlist without therapy. All participants will undergo non-invasive brain activity (EEG) and emotional response (GSR) recordings before and after the therapy.

The study's main question is: Does participating in a 12-week CRT program improve brain-based markers of attention and emotional regulation in people with schizophrenia?

Additional tests, such as memory and emotion recognition tasks and self-report questionnaires, will help assess changes in thinking skills and emotional well-being. The study may help better understand how CRT affects both brain function and quality of life in schizophrenia.

详细描述

This is a randomized controlled trial examining the effects of Cognitive Remediation Therapy (CRT) on neurophysiological and behavioral outcomes in schizophrenia. The primary goal is to assess whether CRT improves attentional control, sensory processing, executive function, and emotional regulation as measured by EEG and GSR.

Sixty participants will be enrolled: 30 individuals diagnosed with schizophrenia (DSM-5 criteria) and 30 healthy controls matched by age and gender. The schizophrenia group will be randomized into a CRT intervention arm and a waitlist control group. Healthy controls will not undergo CRT but will participate in baseline neurophysiological assessments to establish normative EEG and GSR values.

CRT will consist of 12 weekly sessions (approximately 60 minutes each), targeting cognitive domains such as working memory, attention, executive function, and emotion regulation using structured exercises and computer-based tasks.

EEG recordings will include P300 (oddball paradigm), mismatch negativity (MMN), and frontal theta power (cognitive control tasks). GSR will assess baseline skin conductance and reactivity to negative emotional stimuli. Behavioral tasks include the Stroop task, digit span, and facial emotion recognition.

Psychometric instruments include the Turkish-validated versions of:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • (Schizophrenia Group):
  • Diagnosed with schizophrenia according to DSM-5 criteria
  • Age between 18 and 55 years
  • Clinically stable (no hospitalization or medication change within 1 month)
  • Minimum primary school education
  • Able to provide informed consent
  • Right-handed (for EEG protocol consistency)
  • Inclusion Criteria (Healthy Control Group):
  • No history of psychiatric or neurological disorders
  • Age- and gender-matched to schizophrenia group
  • No current medication affecting CNS
  • Able to provide informed consent
  • Right-handed

排除标准

  • (Both Groups):
  • Current or past substance use disorder (within the past year)
  • Comorbid neurological illness (e.g., epilepsy, traumatic brain injury)
  • Current use of benzodiazepines or medications that significantly affect cognitive function
  • Intellectual disability or MoCA score < 20
  • Visual or hearing impairments that could interfere with task performance
  • Participation in a psychological intervention in the last 3 months

结局指标

主要结局

Change from Baseline in P300 Amplitude Measured via EEG at 12 Weeks

时间窗: Baseline and 12 Weeks Post-Intervention

P300 amplitude will be recorded during an auditory oddball task using EEG. Increased P300 amplitude after the 12-week CRT intervention is interpreted as an improvement in attentional processing and cognitive engagement. P300 is a continuous electrophysiological variable typically ranging from 0 to 15 microvolts; higher values post-intervention suggest enhanced neurocognitive performance.

次要结局

  • Change from Baseline in Mismatch Negativity (MMN) Amplitude Measured via EEG at 12 Weeks(Baseline and 12 Weeks Post-Intervention)
  • Change from Baseline in Brief Assessment of Cognition in Schizophrenia (BACS) Total Score at 12 Weeks(Baseline and 12 Weeks Post-Intervention)
  • Change from Baseline in Schizophrenia Quality of Life Scale (SQLS) Total Score at 12 Weeks(Baseline and 12 Weeks Post-Intervention)
  • Change from Baseline in Frontal Midline Theta Power During Cognitive Tasks at 12 Weeks(Baseline and 12 Weeks Post-Intervention)
  • Change from Baseline in Skin Conductance Response (SCR) to Emotional Stimuli at 12 Weeks(Baseline and 12 Weeks Post-Intervention)
  • Change from Baseline in Difficulties in Emotion Regulation Scale (DERS) Total Score at 12 Weeks(Baseline and 12 Weeks Post-Intervention)

研究者

发起方
Beykoz University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eda Yilmazer

Principle investigator

Beykoz University

研究点 (2)

Loading locations...

相似试验